Literature DB >> 25015240

Statins as adjunct therapy in COPD: how do we cope after STATCOPE?

Robert P Young1, Raewyn J Hopkins1, Alvar Agusti2.   

Abstract

Keywords:  COPD Exacerbations; COPD Pharmacology; COPD epidemiology; Cytokine Biology

Mesh：

Substances：

Year:  2014        PMID： 25015240     DOI： 10.1136/thoraxjnl-2014-205814

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  12 in total

1.  Fibrinogen and COPD: Now what?

Authors:  Rosa Faner; Alvar Agusti
Journal:  Chronic Obstr Pulm Dis       Date:  2015-01-24

Review 2.  Innovations in asthma therapy: is there a role for inhaled statins?

Authors:  Amir A Zeki; Mona Elbadawi-Sidhu
Journal:  Expert Rev Respir Med       Date:  2018-05-03       Impact factor: 3.772

Review 3.  Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.

Authors:  Michael Schivo; Timothy E Albertson; Angela Haczku; Nicholas J Kenyon; Amir A Zeki; Brooks T Kuhn; Samuel Louie; Mark V Avdalovic
Journal:  J Investig Med       Date:  2017-03-03       Impact factor: 2.895

4.  Genome Expression Profiling-Based Identification and Administration Efficacy of Host-Directed Antimicrobial Drugs against Respiratory Infection by Nontypeable Haemophilus influenzae.

Authors:  Begoña Euba; Javier Moleres; Víctor Segura; Cristina Viadas; Pau Morey; David Moranta; José Leiva; Juan Pablo de-Torres; José Antonio Bengoechea; Junkal Garmendia
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

5.  Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation.

Authors:  Federico Rea; Giulia Calusi; Matteo Franchi; Davide Liborio Vetrano; Giuseppe Roberto; Stefano Bonassi; Ursula Kirchmayer; Alessandro Chinellato; Alessandra Bettiol; Janet Sultana; Alessandro Mugelli; Giovanni Corrao
Journal:  Drugs Aging       Date:  2018-12       Impact factor: 3.923

6.  Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.

Authors:  Kittipong Maneechotesuwan; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  Respir Res       Date:  2016-08-24

7.  Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.

Authors:  Kittipong Maneechotesuwan; Adisak Wongkajornsilp; Ian M Adcock; Peter J Barnes
Journal:  Chest       Date:  2015-11       Impact factor: 9.410

8.  Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.

Authors:  Chieh-Mo Lin; Tsung-Ming Yang; Yao-Hsu Yang; Ying-Huang Tsai; Chuan-Pin Lee; Pau-Chung Chen; Wen-Cheng Chen; Meng-Jer Hsieh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-10

9.  Efficacy and safety of statin therapy in pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Fangying Chen; Mei Yang; Chun Wan; Lin Liu; Lei Chen
Journal:  Ann Transl Med       Date:  2019-12

10.  Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies.

Authors:  Wen-Feng Li; Yu-Qing Huang; Cheng Huang; Ying-Qing Feng
Journal:  Oncotarget       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.